CRISPRi screen of long non-coding RNAs identifies LINC03045 regulating glioblastoma invasion.


Journal

PLoS genetics
ISSN: 1553-7404
Titre abrégé: PLoS Genet
Pays: United States
ID NLM: 101239074

Informations de publication

Date de publication:
10 Jun 2024
Historique:
received: 10 05 2023
accepted: 21 05 2024
medline: 10 6 2024
pubmed: 10 6 2024
entrez: 10 6 2024
Statut: aheadofprint

Résumé

Glioblastoma (GBM) invasion studies have focused on coding genes, while few studies evaluate long non-coding RNAs (lncRNAs), transcripts without protein-coding potential, for role in GBM invasion. We leveraged CRISPR-interference (CRISPRi) to evaluate invasive function of GBM-associated lncRNAs in an unbiased functional screen, characterizing and exploring the mechanism of identified candidates. We implemented a CRISPRi lncRNA loss-of-function screen evaluating association of lncRNA knockdown (KD) with invasion capacity in Matrigel. Top screen candidates were validated using CRISPRi and oligonucleotide(ASO)-mediated knockdown in three tumor lines. Clinical relevance of candidates was assessed via The Cancer Genome Atlas(TCGA) and Genotype-Tissue Expression(GTEx) survival analysis. Mediators of lncRNA effect were identified via differential expression analysis following lncRNA KD and assessed for tumor invasion using knockdown and rescue experiments. Forty-eight lncRNAs were significantly associated with 33-83% decrease in invasion (p<0.01) upon knockdown. The top candidate, LINC03045, identified from effect size and p-value, demonstrated 82.7% decrease in tumor cell invasion upon knockdown, while LINC03045 expression was significantly associated with patient survival and tumor grade(p<0.0001). RNAseq analysis of LINC03045 knockdown revealed that WASF3, previously implicated in tumor invasion studies, was highly correlated with lncRNA expression, while WASF3 KD was associated with significant decrease in invasion. Finally, WASF3 overexpression demonstrated rescue of invasive function lost with LINC03045 KD. CRISPRi screening identified LINC03045, a previously unannotated lncRNA, as critical to GBM invasion. Gene expression is significantly associated with tumor grade and survival. RNA-seq and mechanistic studies suggest that this novel lncRNA may regulate invasion via WASF3.

Identifiants

pubmed: 38857306
doi: 10.1371/journal.pgen.1011314
pii: PGENETICS-D-23-00531
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1011314

Informations de copyright

Copyright: © 2024 Tsung et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Kathleen Tsung (K)

Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.

Kristie Q Liu (KQ)

Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.

Jane S Han (JS)

Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.

Krutika Deshpande (K)

Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.

Tammy Doan (T)

Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.

Yong-Hwee Eddie Loh (YE)

USC Libraries Bioinformatics Services, University of Southern California, Los Angeles, California, United States of America.

Li Ding (L)

Department of Preventative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.

Wentao Yang (W)

Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.

Josh Neman (J)

Department of Neurological Surgery, Physiology and Neuroscience, USC Brain Tumor Center, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.

Yali Dou (Y)

Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.

Frank J Attenello (FJ)

Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.

Classifications MeSH